Skip to main content
Gretel Terrero, MD, Oncology, Miami, FL, UMHC-Sylvester Comprehensive Cancer Center

GretelTerreroMD(She/Her)

Oncology Miami, FL

Gastrointestinal Cancer

Assistant Professor of Clinical Medicine

Dr. Terrero is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Terrero's full profile

Already have an account?

  • Office

    Sylvester Comprehensive Cancer Center
    1475 NW 12th Ave, FL 2
    Miami, FL 33136
    Phone+1 305-243-6606
    Fax+1 305-243-4975
  • Is this information wrong?

Summary

  • Triple-board certified Hematologist/Oncologist, specializing in gastrointestinal oncology. Diagnoses treated include esophagus, gastric, hepatobiliary, pancreas, small bowel, colorectal, and anal cancers. Currently seeing patients at Sylvester Comprehensive Cancer Center at the Miami and Doral locations.

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2018 - 2021
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2016 - 2018
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2015 - 2016
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2015

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - 2025
  • MA State Medical License
    MA State Medical License 2015 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Exceptional responses to ipilimumab/nivolumab (ipi/nivo) in patients (pts) with refractory pancreatic ductal adenocarcinoma (PDAC) and germline BRCA or RAD51 mutations. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020

Press Mentions

  • Colon Cancer: Might Dietary Changes Help Starve Tumors?
    Colon Cancer: Might Dietary Changes Help Starve Tumors?November 24th, 2022

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations